Replies to post #2335 on Bio Path Holdings Inc (BPTH)

[Gpheart2016]

Tyrone, BPTH ran up to $5.25 in Jan 2014 after completion of five cohorts of phase 1 study showing efficacy and lack of toxicity. That news resulted in new buyers and increased volume. I suspect that some buyers contributed to the frenzy while planning to then short the stock (this is a common practice that biotech investors use). I do not see evidence of a "Wasatch front scam".